Matuo Y, McKeehan W L, Yan G C, Nikolaropoulos S, Adams P S, Fukabori Y, Yamanaka H, Gaudreau J
W. Alton Jones Cell Science Center, Lake Placid, NY 12946.
Adv Exp Med Biol. 1992;324:107-14. doi: 10.1007/978-1-4615-3398-6_11.
We review in this paper the role of heparin-binding growth factor (HBGF*) or fibroblast growth factor (FGF*), rat prostate cancer cells produce TGF-beta, IGF-II* and OGF*. Of these growth factors, TGF-beta and unknown labile factor with 19 kDa are the most probable candidates responsible for osteoblastic bony metastasis of prostate cancer. In vitro experiments suggest that TGF-beta modulates cell detachment of prostate cancer cells together with nutritional factors. HBGF-dependent growth of the prostate tumor epithelial cells is free from inhibition by TGF-beta, whereas normal prostate epithelial cells are sensitive to TGF-beta inhibition. Transfection experiments suggest that HBGF-2 (basic FGF) might be closely related to the malignant growth of prostate cancer, in addition to tumor angiogenesis.